Home Applications 209296 Application 209296
Type NDA
Sponsor HERON THERAPS INC Application Products# Product, Drug, Ingredient table Product Drug Ingredient Form Strength Reference drug Reference standard 001 CINVANTI APREPITANT EMULSION;INTRAVENOUS 130MG/18ML (7.2MG/ML) Yes Yes
Source provenance: Browse the complete Orange Book source catalog · source snapshot 42 .
Orange Book products# Current product rows page 1 of 1 · 1 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N209296-001 CINVANTI APREPITANT 130MG/18ML (7.2MG/ML) EMULSION / INTRAVENOUS RLD, RS 2017-11-09
Orange Book patents# Current patent rows page 1 of 1 · 13 matching rows.
Application-product, Patent, Expiration table Application-product Patent Expiration Use code Coverage / status Submission date N209296-001 10500208 2035-09-18 Drug product 2019-12-23 N209296-001 10624850 2035-09-18 U-2161 2020-04-30 N209296-001 10953018 2035-09-18 U-2161 2021-04-08 N209296-001 11173118 2035-09-18 Drug product 2021-12-13 N209296-001 11744800 2035-09-18 Drug product 2023-10-02 N209296-001 12115254 2035-09-18 Drug product 2024-11-07 N209296-001 12115255 2035-09-18 Drug product 2024-11-07 N209296-001 12290520 2035-09-18 Drug product 2025-05-12 N209296-001 9561229 2035-09-18 U-2161 Drug product 2017-12-05 N209296-001 9808465 2035-09-18 U-2161 2017-12-05 N209296-001 9974742 2035-09-18 Drug product 2018-06-19 N209296-001 9974793 2035-09-18 Drug product 2018-06-19 N209296-001 9974794 2035-09-18 U-2161 Drug product 2018-06-19
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 2 · 42 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-08-18 06:07:40 2026-07 N209296-001 CINVANTI 130MG/18ML (7.2MG/ML) EMULSION / INTRAVENOUS RLD, RS 2017-11-09 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N209296-001 CINVANTI 130MG/18ML (7.2MG/ML) EMULSION / INTRAVENOUS RLD, RS 2017-11-09 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N209296-001 CINVANTI 130MG/18ML (7.2MG/ML) EMULSION / INTRAVENOUS RLD, RS 2017-11-09 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N209296-001 CINVANTI 130MG/18ML (7.2MG/ML) EMULSION / INTRAVENOUS RLD, RS 2017-11-09 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N209296-001 CINVANTI 130MG/18ML (7.2MG/ML) EMULSION / INTRAVENOUS RLD, RS 2017-11-09 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N209296-001 CINVANTI 130MG/18ML (7.2MG/ML) EMULSION / INTRAVENOUS RLD, RS 2017-11-09 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N209296-001 CINVANTI 130MG/18ML (7.2MG/ML) EMULSION / INTRAVENOUS RLD, RS 2017-11-09 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N209296-001 CINVANTI 130MG/18ML (7.2MG/ML) EMULSION / INTRAVENOUS RLD, RS 2017-11-09 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N209296-001 CINVANTI 130MG/18ML (7.2MG/ML) EMULSION / INTRAVENOUS RLD, RS 2017-11-09 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N209296-001 CINVANTI 130MG/18ML (7.2MG/ML) EMULSION / INTRAVENOUS RLD, RS 2017-11-09 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 N209296-001 CINVANTI 130MG/18ML (7.2MG/ML) EMULSION / INTRAVENOUS RLD, RS 2017-11-09 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N209296-001 CINVANTI 130MG/18ML (7.2MG/ML) EMULSION / INTRAVENOUS RLD, RS 2017-11-09 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N209296-001 CINVANTI 130MG/18ML (7.2MG/ML) EMULSION / INTRAVENOUS RLD, RS 2017-11-09 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N209296-001 CINVANTI 130MG/18ML (7.2MG/ML) EMULSION / INTRAVENOUS RLD, RS 2017-11-09 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 N209296-001 CINVANTI 130MG/18ML (7.2MG/ML) EMULSION / INTRAVENOUS RLD, RS 2017-11-09 8072bd15b7f6…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 N209296-001 CINVANTI 130MG/18ML (7.2MG/ML) EMULSION / INTRAVENOUS RLD, RS 2017-11-09 5c6f7cd8ea54…2022-04-08 23:34 UTC 2022-04 N209296-001 CINVANTI 130MG/18ML (7.2MG/ML) EMULSION / INTRAVENOUS RLD, RS 2017-11-09 5d02ea3f76ae…2022-04-04 05:41 UTC 2022-04 N209296-001 CINVANTI 130MG/18ML (7.2MG/ML) EMULSION / INTRAVENOUS RLD, RS 2017-11-09 4b0b4de00fa7…2019-12-13 00:20 UTC 2019-12 N209296-001 CINVANTI 130MG/18ML (7.2MG/ML) EMULSION / INTRAVENOUS RLD, RS 2017-11-09 74a2ff9319b5…2022-03-09 01:35 UTC 2022-03 N209296-001 CINVANTI 130MG/18ML (7.2MG/ML) EMULSION / INTRAVENOUS RLD, RS 2017-11-09 bb7c543d1eb4…2021-12-28 21:50 UTC 2021-12 N209296-001 CINVANTI 130MG/18ML (7.2MG/ML) EMULSION / INTRAVENOUS RLD, RS 2017-11-09 782e0a99824c…2021-05-05 16:15 UTC · 3 captures of this ZIP 2021-05 N209296-001 CINVANTI 130MG/18ML (7.2MG/ML) EMULSION / INTRAVENOUS RLD, RS 2017-11-09 87673890dc5c…2021-03-12 10:30 UTC 2021-03 N209296-001 CINVANTI 130MG/18ML (7.2MG/ML) EMULSION / INTRAVENOUS RLD, RS 2017-11-09 5aa47cf7b7d7…2020-12-22 03:56 UTC 2020-12 N209296-001 CINVANTI 130MG/18ML (7.2MG/ML) EMULSION / INTRAVENOUS RLD, RS 2017-11-09 8869cabd3fbd…2020-11-12 02:37 UTC 2020-11 N209296-001 CINVANTI 130MG/18ML (7.2MG/ML) EMULSION / INTRAVENOUS RLD, RS 2017-11-09 c0c555d07b60…2019-12-14 00:12 UTC 2019-12 N209296-001 CINVANTI 130MG/18ML (7.2MG/ML) EMULSION / INTRAVENOUS RLD, RS 2017-11-09 3f01610625f2…2019-09-15 20:21 UTC 2019-09 N209296-001 CINVANTI 130MG/18ML (7.2MG/ML) EMULSION / INTRAVENOUS RLD, RS 2017-11-09 b00525d2431f…2019-07-19 19:46 UTC 2019-07 N209296-001 CINVANTI 130MG/18ML (7.2MG/ML) EMULSION / INTRAVENOUS RLD, RS 2017-11-09 ea99ee380514…2024-03-16 18:09 UTC · 4 captures of this ZIP 2024-03 N209296-001 CINVANTI 130MG/18ML (7.2MG/ML) EMULSION / INTRAVENOUS RLD, RS 2017-11-09 6a51e52b5d6a…2024-02-18 07:12 UTC 2024-02 N209296-001 CINVANTI 130MG/18ML (7.2MG/ML) EMULSION / INTRAVENOUS RLD, RS 2017-11-09 1c564ffb4f44…2023-12-20 04:57 UTC 2023-12 N209296-001 CINVANTI 130MG/18ML (7.2MG/ML) EMULSION / INTRAVENOUS RLD, RS 2017-11-09 ea1830bbd6c7…2023-11-28 05:40 UTC · 2 captures of this ZIP 2023-11 N209296-001 CINVANTI 130MG/18ML (7.2MG/ML) EMULSION / INTRAVENOUS RLD, RS 2017-11-09 a72a2bbeb626…2023-10-25 00:34 UTC · 2 captures of this ZIP 2023-10 N209296-001 CINVANTI 130MG/18ML (7.2MG/ML) EMULSION / INTRAVENOUS RLD, RS 2017-11-09 9b2671bbb829…2023-07-15 15:27 UTC · 2 captures of this ZIP 2023-07 N209296-001 CINVANTI 130MG/18ML (7.2MG/ML) EMULSION / INTRAVENOUS RLD, RS 2017-11-09 a67488948f0b…2023-06-13 01:57 UTC · 3 captures of this ZIP 2023-06 N209296-001 CINVANTI 130MG/18ML (7.2MG/ML) EMULSION / INTRAVENOUS RLD, RS 2017-11-09 3f0d92c62455…2023-05-13 08:27 UTC 2023-05 N209296-001 CINVANTI 130MG/18ML (7.2MG/ML) EMULSION / INTRAVENOUS RLD, RS 2017-11-09 053a50430f4f…2023-01-26 05:58 UTC 2023-01 N209296-001 CINVANTI 130MG/18ML (7.2MG/ML) EMULSION / INTRAVENOUS RLD, RS 2017-11-09 3bdfa0b2c4d7…2022-11-12 20:34 UTC · 5 captures of this ZIP 2022-11 N209296-001 CINVANTI 130MG/18ML (7.2MG/ML) EMULSION / INTRAVENOUS RLD, RS 2017-11-09 3a93d1ddd44b…2022-10-28 04:53 UTC 2022-10 N209296-001 CINVANTI 130MG/18ML (7.2MG/ML) EMULSION / INTRAVENOUS RLD, RS 2017-11-09 f41ea6bd6efb…2022-09-29 23:25 UTC 2022-09 N209296-001 CINVANTI 130MG/18ML (7.2MG/ML) EMULSION / INTRAVENOUS RLD, RS 2017-11-09 e64feba35796…
Observed Orange Book patent history# Patent history page 1 of 10 · 397 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Patent Expiration Use code Coverage / status Submission date Source SHA-256 2026-08-18 06:07:40 2026-07 N209296-001 10500208 2035-09-18 Drug product 2019-12-23 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N209296-001 10624850 2035-09-18 U-2161 2020-04-30 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N209296-001 10953018 2035-09-18 U-2161 2021-04-08 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N209296-001 11173118 2035-09-18 Drug product 2021-12-13 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N209296-001 11744800 2035-09-18 Drug product 2023-10-02 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N209296-001 12115254 2035-09-18 Drug product 2024-11-07 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N209296-001 12115255 2035-09-18 Drug product 2024-11-07 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N209296-001 12290520 2035-09-18 Drug product 2025-05-12 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N209296-001 9561229 2035-09-18 U-2161 Drug product 2017-12-05 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N209296-001 9808465 2035-09-18 U-2161 2017-12-05 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N209296-001 9974742 2035-09-18 Drug product 2018-06-19 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N209296-001 9974793 2035-09-18 Drug product 2018-06-19 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N209296-001 9974794 2035-09-18 U-2161 Drug product 2018-06-19 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N209296-001 10500208 2035-09-18 Drug product 2019-12-23 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N209296-001 10624850 2035-09-18 U-2161 2020-04-30 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N209296-001 10953018 2035-09-18 U-2161 2021-04-08 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N209296-001 11173118 2035-09-18 Drug product 2021-12-13 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N209296-001 11744800 2035-09-18 Drug product 2023-10-02 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N209296-001 12115254 2035-09-18 Drug product 2024-11-07 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N209296-001 12115255 2035-09-18 Drug product 2024-11-07 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N209296-001 12290520 2035-09-18 Drug product 2025-05-12 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N209296-001 9561229 2035-09-18 U-2161 Drug product 2017-12-05 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N209296-001 9808465 2035-09-18 U-2161 2017-12-05 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N209296-001 9974742 2035-09-18 Drug product 2018-06-19 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N209296-001 9974793 2035-09-18 Drug product 2018-06-19 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N209296-001 9974794 2035-09-18 U-2161 Drug product 2018-06-19 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N209296-001 10500208 2035-09-18 Drug product 2019-12-23 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N209296-001 10624850 2035-09-18 U-2161 2020-04-30 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N209296-001 10953018 2035-09-18 U-2161 2021-04-08 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N209296-001 11173118 2035-09-18 Drug product 2021-12-13 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N209296-001 11744800 2035-09-18 Drug product 2023-10-02 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N209296-001 12115254 2035-09-18 Drug product 2024-11-07 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N209296-001 12115255 2035-09-18 Drug product 2024-11-07 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N209296-001 12290520 2035-09-18 Drug product 2025-05-12 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N209296-001 9561229 2035-09-18 U-2161 Drug product 2017-12-05 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N209296-001 9808465 2035-09-18 U-2161 2017-12-05 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N209296-001 9974742 2035-09-18 Drug product 2018-06-19 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N209296-001 9974793 2035-09-18 Drug product 2018-06-19 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N209296-001 9974794 2035-09-18 U-2161 Drug product 2018-06-19 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N209296-001 10500208 2035-09-18 Drug product 2019-12-23 6a471c1ec25d…
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
NDC Listings For This Application# NDC listings for this application page 1 of 1 · 3 matching rows.
NDC, Name, Nonproprietary name table NDC Name Nonproprietary name Labeler Marketing category Status 47426-201 CINVANTI aprepitant Heron Therapeutics, Inc. NDA Current 47426-201 CINVANTI aprepitant Heron Therapeutics, Inc. NDA Current 47426-201 CINVANTI aprepitant Heron Therapeutics, Inc. NDA Current
Documents# Document, Submission type, Date table Document Submission type Date 77721 SUPPL 2024-03-05 77716 SUPPL 2024-03-05 70796 SUPPL 2022-04-20 70522 SUPPL 2022-03-15 60632 SUPPL 2019-10-22 60630 SUPPL 2019-10-22 57833 SUPPL 2019-02-28 57823 SUPPL 2019-02-27 52881 ORIG 2018-03-09 50385 ORIG 2017-11-13 50368 ORIG 2017-11-13